Oral Session 1-11B Basic and clinical studies for immunotherapy

[OS1-11B-6] Tax targeting dendritic cell vaccine for ATL: A phase Ia/Ib clinical study

Youko Suehiro¹, Tetsuya Fukuda², Motoaki Shirathuchi³, Tadafumi Iino⁴, Atsuhiko Hasegawa⁵, Jun-Ichiro Yasunaga⁶, Akie Hirata⁷, Hayato Utsunomiya¹, Hirofumi Ohno¹, Takashi Ishida⁸, Koichi Akashi⁹, Masao Matsuoka¹⁰, Mari Kannagi⁵ (1.Department of Cell Therapy, National Kyushu Cancer Center, Fukuoka, Japan, 2.Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan, 3.Department of Medicine and Bioregulatory Science,Kyushu University, Fukuoka, Japan, 4.Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan, 5.Department of Immunotherapeutics, Tokyo Medical and Dental University, Tokyo, Japan, 6.Laboratory of Virus Control, Kyoto University, Kyoto, Japan, 7.Department of Clinical Laboratory, National Kyushu Cancer Center, Fukuoka, Japan, 8.Division of Hematology and Oncology, Iwate Medical University, Iwate, Japan, 9.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 10.Department of Hematology, Kumamoto University, Kumamoto, Japan)